RecruitingNCT07058935
The Asia-Pacific Mitral & Tricuspid Valve-in-Valve/Valve-in-Ring Registry (AP ViV Registry)
Sponsor
National Heart Centre Singapore
Enrollment
150 participants
Start Date
Mar 17, 2025
Study Type
OBSERVATIONAL
Conditions
Summary
A retrospective and prospective, observational, multicenter cohort study of consecutive patients undergoing transcatheter mitral/tricuspid ViV or ViR procedure with balloon expandable valve across participating sites in Asia-Pacific.
Eligibility
Min Age: 21 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with valve disease, heart. The study is currently recruiting participants at 8 locations. People eligible for this study include aged 21 Years and older.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(8)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07058935
Related Trials
Observational Study of Patients Undergoing Diagnostic Right Heart Catheterization
NCT072249061 location
Medtronic Cardiac Surgery PMCF Registry
NCT0407342026 locations
Mosaic Mitral Valve: Long-Term Outcomes in Patients Under 65
NCT069175861 location
Valvular Heart Disease in Women Registry
NCT071969302 locations
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
NCT059720701 location